IVIVC Revised

Nikolaos Alimpertis,Antony Simitopoulos,Athanasios A. Tsekouras,Panos Macheras

DOI: https://doi.org/10.1007/s11095-024-03653-x

IF: 4.58

2024-01-10

Pharmaceutical Research

Abstract:To revise the IVIVC considering the physiologically sound Finite Absorption Time (F.A.T.) and Finite Dissolution Time (F.D.T.) concepts.

pharmacology & pharmacy,chemistry, multidisciplinary

What problem does this paper attempt to address?

Application of the Finite Absorption Time (F.A.T.) Concept in the Assessment of Bioequivalence

Athanasios A. Tsekouras,Panos Macheras

DOI: https://doi.org/10.1007/s11095-024-03727-w

IF: 4.58

2024-06-21

Pharmaceutical Research

Abstract:Το formulate a methodology for the assessment of bioequivalence using metrics, which are based on the physiologically sound F.A.T. concept.

pharmacology & pharmacy,chemistry, multidisciplinary
IV-IVC considerations in the development of immediate-release oral dosage form

Shoufeng Li,Handan He,Lakshman J. Parthiban,Hequn Yin,Abu T.M. Serajuddin

DOI: https://doi.org/10.1002/jps.20378

IF: 3.8

2005-07-01

Journal of Pharmaceutical Sciences

Abstract:Predictive scientific principles and methods to assess in vivo performance of pharmaceutical dosage forms based on in vitro studies are important in order to minimize costly animal and human experiments during drug development. Because of issues related to poor solubility and low permeability of newer drug candidates, there has in recent years been a special focus on in vitro-in vivo correlation (IV-IVC) of drug products, particularly those used orally. Various physicochemical, biopharmaceutical, and physiological factors that need to be considered in successful IV-IVC of immediate-release oral dosage forms are reviewed in this article. The physicochemical factors include drug solubility in water and physiologically relevant aqueous media, pK(a) and drug ionization characteristics, salt formation, drug diffusion-layer pH, particle size, polymorphism of drug substance, and so forth. The biopharmaceutical factors that need to be considered include effects of drug ionization, partition coefficient, polar surface area, etc., on drug permeability, and some of the physiological factors are gastrointestinal (GI) content, GI pH, GI transit time, etc. Various in silico, in vitro, and in vivo methods of estimating drug permeability and absorption are discussed. Additionally, how IV-IVC may be applied to immediate-release oral dosage form design are presented.

pharmacology & pharmacy,chemistry, medicinal, multidisciplinary
Conventional vs Mechanistic IVIVC: A Comparative Study in Establishing Dissolution Safe Space for Extended Release Formulations

Sivacharan Kollipara,Tausif Ahmed,Mahendra Chougule,Chakravarthi Guntupalli,Praveen Sivadasu

DOI: https://doi.org/10.1208/s12249-024-02819-5

IF: 3.3

2024-05-30

AAPS PharmSciTech

Abstract:The use of in vitro - in vivo correlation (IVIVC) for extended release oral dosage forms is an important technique that can avoid potential clinical studies. IVIVC has been a topic of discussion over the past two decades since the inception of USFDA guidance. It has been routinely used for biowaivers, establishment of dissolution safe space and clinically relevant dissolution specifications, for supporting site transfers, scale-up and post approval changes. Although conventional or mathematical IVIVC is routinely used, other approach such as mechanistic IVIVC can be of attractive choice as it integrates all the physiological aspects. In the present study, we have performed comparative evaluation of mechanistic and conventional IVIVC for establishment of dissolution safe space using divalproex sodium and tofacitinib extended release formulations as case examples. Conventional IVIVC was established using Phoenix and mechanistic IVIVC was set up using Gastroplus physiologically based biopharmaceutics model (PBBM). Virtual dissolution profiles with varying release rates were constructed around target dissolution profile using Weibull function. After internal and external validation, the virtual dissolution profiles were integrated into mechanistic and conventional IVIVC and safe space was established by absolute error and T/R ratio's methods. The results suggest that mechanistic IVIVC yielded wider safe space as compared to conventional IVIVC. The results suggest that a mechanistic approach of establishing IVIVC may be a flexible approach as it integrates physiological aspects. These findings suggest that mechanistic IVIVC has wider potential as compared to conventional IVIVC to gain wider dissolution safe space and thus can avoid potential clinical studies. Graphical

pharmacology & pharmacy
FDA and EMA Oversight of Disruptive Science on Application of Finite Absorption Time (F.A.T.) Concept in Oral Drug Absorption: Time for Scientific and Regulatory Changes

Elias Toulitsis,Athanasios A. Tsekouras,Panos Macheras

DOI: https://doi.org/10.3390/pharmaceutics16111435

IF: 6.525

2024-11-13

Pharmaceutics

Abstract:Background: It has been demonstrated that the concept of infinite absorption time, associated with the absorption rate constant, which drives a drug's gastrointestinal absorption rate, is not physiologically sound. The recent analysis of oral drug absorption data based on the finite absorption time (F.A.T.) concept and the relevant physiologically based finite-time pharmacokinetic (PBFTPK) models developed provided a better physiologically sound description of oral drug absorption. Methods: In this study, we re-analyzed, using PBFTPK models, seven data sets of ketoprofen, amplodipine, theophylline (three formulations), and two formulations (reference, test) from a levonorgestrel bioequivalence study. Equations for one-compartment-model drugs, for the estimation of fraction of dose absorbed or the bioavailable fraction exclusively from oral data, were developed. Results: In all cases, meaningful estimates for (i) the number of absorption stages, namely, one for ketoprofen and the levonorgestrel formulations, two for amlodipine, the immediate-release theophylline formulation, and the extended-release Theotrim formulation, and three for the extended-release Theodur formulation, (ii) the duration of each absorption stage and the corresponding drug input rate, and (iii) the total duration of drug absorption, which ranged from 0.75 h (ketoprofen) to 11.6 h for Theodur were derived. Estimates for the bioavailable fraction of ketoprofen and two theophylline formulations exhibiting one-compartment-model kinetics were derived. Conclusions: This study provides insights into the detailed characteristics of oral drug absorption. The use of PBFTPK models in drug absorption analysis can be leveraged as a computational framework to discontinue the perpetuation of the mathematical fallacy of classical pharmacokinetic analysis based on the absorption rate constant as well as in the physiologically based pharmacokinetic (PBPK) studies and pharmacometrics. The present study is an additional piece of evidence for the scientific and regulatory changes required to be implemented by the regulatory agencies in the not-too-distant future.

pharmacology & pharmacy
Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts

Panos Macheras,Pavlos Chryssafidis

DOI: https://doi.org/10.1007/s11095-020-02894-w

IF: 4.58

2020-09-04

Pharmaceutical Research

Abstract:To demonstrate that oral drug absorption is terminated in finite time. To develop models based on biopharmaceutical/physiological and finite absorption time concepts.

pharmacology & pharmacy,chemistry, multidisciplinary
A time-scaled convolution approach to construct IVIVC for enteric-coated acetylsalicylic acid tablets

J Al-Gousous,P Langguth

DOI: https://doi.org/10.1691/ph.2018.7136

2018-02-01

Pharmazie

Abstract:A scaled convolution-based in vitro-in vivo (IVIVC) model was constructed for two enteric-coated acetylsalicylic acid tablet formulations. The in vitro data used were the results of dissolution testing performed using three different dissolution methods: the United States Pharmacopoeia (USP) method, a method employing blank Fasted State Simulated Fluid (FaSSIF), and a new method developed in house. The in vivo data were obtained from a pharmacokinetic study on human subjects in the fasted state. When the new dissolution method results were used, an average prediction error less than 10% and a maximum prediction error less than 15% were obtained for the peak plasma concentration (Cmax) and area under the curve (AUC) parameters, thus meeting the internal validation criteria of the IVIVC guidance of the US Food and Drug Administration (FDA).
FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms

Cynthia K. Brown,Horst Dieter Friedel,Amy R. Barker,Lucinda F. Buhse,Susanne Keitel,Todd L. Cecil,Johannes Kraemer,J. Michael Morris,Christos Reppas,Mary P. Stickelmeyer,Chikako Yomota,Vinod P. Shah

DOI: https://doi.org/10.1208/s12249-011-9634-x

IF: 3.3

2011-06-01

AAPS PharmSciTech

Abstract:In 2003, the FIP Dissolution Working group published a position paper on dissolution/drug release testing for special/novel dosage forms that represented the scientific opinions of many experts in the field at that time (1). The position paper has supported activities, programs, and decisions in the scientific, technical, and regulatory community. Due to the rapid evolution of new practices and techniques for in vitro testing, the FIP Special Interest Group (SIG) on Dissolution/Drug Release decided to revise the previous paper and added proposals for further harmonization of in vitro release testing practices for different pharmaceutical dosage forms. This article represents the current updates to the previously published paper. This revision has been aligned to coincide with the USP taxonomy including route of administration, intended site of drug release, and dosage form. The revised paper includes information from current literature, expert discussions, and presentations from recent workshops (2,3). The authors acknowledge and expect further updates to be made as additional progress is made in the relevant areas. Thus, comments and additional contributions are welcome and may be considered for the next revision of the position paper.

pharmacology & pharmacy
Direct, differential-equation-based in-vitro-in-vivo correlation (IVIVC) method

Peter Buchwald

DOI: https://doi.org/10.1211/002235702847

Abstract:A new, differential equation-based in-vitro-in-vivo correlation (IVIVC) method is proposed that directly relates the time-profiles of in-vitro dissolution rates and in-vivo plasma concentrations by using one- or multi-compartment pharmacokinetic models and a corresponding system of differential equations. The rate of in-vivo input is connected to the rate of in-vitro dissolution through a general functional dependency that allows for time scaling and time shifting. A multiplying factor that accounts for the variability of absorption conditions as the drug moves along is also incorporated. Two data sets incorporating slow-, medium-, and fast-release formulations were used to test the applicability of the method, and predictive powers were assessed with a leave-one-formulation-out approach. All fitted parameters had realistic values, and good or acceptable fits and predictions were obtained as measured by plasma concentration mean squared errors and percent AUC errors. Introduction of step-down functions that account for the transit of the dosage form past the intestinal sites of absorption proved useful. By avoiding the integral transforms used in the existing deconvolution- or convolution-based IVIVC models, the present method can provide increased transparency, improved performance, and greater modelling flexibility.
In vivo dissolution of poorly water-soluble drugs: Proof of concept based on fluorescence bioimaging

Yinqian Yang,Yongjiu Lv,Chengying Shen,Tingting Shi,Haisheng He,Jianping Qi,Xiaochun Dong,Weili Zhao,Yi Lu,Wei Wu

DOI: https://doi.org/10.1016/j.apsb.2020.08.002

IF: 14.903

2021-04-01

Acta Pharmaceutica Sinica B

Abstract:In vitro‒in vivo correlation (IVIVC) of solid dosage forms should be established basically between in vitro and in vivo dissolution of active pharmaceutical ingredients. Nevertheless, in vivo dissolution profiles have never been accurately portrayed. The current practice of IVIVC has to resort to in vivo absorption fractions (Fa). In this proof-of-concept study, in vivo dissolution of a model poorly water-soluble drug fenofibrate (FNB) was investigated by fluorescence bioimaging. FNB crystals were first labeled by near-infrared fluorophores with aggregation-caused quenching properties. The dyes illuminated FNB crystals but quenched immediately and absolutely once been released into aqueous media, enabling accurate monitoring of residual drug crystals. The linearity established between fluorescence and crystal concentration justified reliable quantification of FNB crystals. In vitro dissolution was first measured following pharmacopoeia monograph protocols with well-documented IVIVC. The synchronicity between fluorescence and in vitro dissolution of FNB supported using fluorescence as a measure for determination of dissolution. In vitro dissolution correlated well with in vivo dissolution, acquired by either live or ex vivo imaging. The newly established IVIVC was further validated by correlating both in vitro and in vivo dissolution with Fa obtained from pharmacokinetic data.

pharmacology & pharmacy
Assessment of fitting methods and variability of IVIM parameters in muscles of the lumbar spine at rest

Erin K Englund,David B Berry,John J Behun,Lawrence R Frank,Samuel R Ward,Bahar Shahidi

DOI: https://doi.org/10.3389/fmscd.2024.1386276

Abstract:Intravoxel incoherent motion (IVIM) MRI provides insight into tissue diffusion and perfusion. Here, estimates of perfusion fraction ( f ), pseudo-diffusion coefficient ( D * ), and diffusion coefficient ( D ) obtained via different fitting methods are compared to ascertain (1) the optimal analysis strategy for muscles of the lumbar spine and (2) repeatability of IVIM parameters in skeletal muscle at rest. Diffusion-weighted images were acquired in the lumbar spine at rest in 15 healthy participants. Data were fit to the bi-exponential IVIM model to estimate f , D * and D using three variably segmented approaches based on non-linear least squares fitting, and a Bayesian fitting method. Assuming that perfusion and diffusion are temporally stable in skeletal muscle at rest, and spatially uniform within a spinal segment, the optimal analysis strategy was determined as the approach with the lowest temporal or spatial variation and smallest residual between measured and fit data. Inter-session repeatability of IVIM parameters was evaluated in a subset of 11 people. Finally, simulated IVIM signal at varying signal to noise ratio were evaluated to understand precision and bias. Experimental results showed that IVIM parameter values differed depending on the fitting method. A three-step non-linear least squares fitting approach, where D , f , and D * were estimated sequentially, generally yielded the lowest spatial and temporal variation. Solving all parameters simultaneously yielded the lowest residual between measured and fit data, however there was substantial spatial and temporal variability. Results obtained by Bayesian fitting had high spatial and temporal variability in addition to a large residual between measured and fit data. Simulations showed that all fitting methods can fit the IVIM data at signal to noise ratios >35, and that D * was the most challenging to accurately obtain. Overall, this study motivates use of a three-step non-linear least squares fitting strategy to quantify IVIM parameters in skeletal muscle.
Development of in Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms

Timothy R. Lex,Jason D. Rodriguez,Lei Zhang,Wenlei Jiang,Ziwen Gao

DOI: https://doi.org/10.1208/s12248-022-00690-5

2022-01-01

Abstract:In vitro dissolution testing is widely used to mimic and predict in vivo performance of oral drug products in the gastrointestinal (GI) tract. This literature review assesses the current in vitro dissolution methodologies being employed to simulate and predict in vivo drug dissolution under fasted and fed conditions, with emphasis on immediate release (IR) solid oral dosage forms. Notable human GI physiological conditions under fasted and fed states have been reviewed and summarized. Literature results showed that dissolution media, mechanical forces, and transit times are key dissolution test parameters for simulating specific postprandial conditions. A number of biorelevant systems, including the fed stomach model (FSM), GastroDuo device, dynamic gastric model (DGM), simulated gastrointestinal tract models (TIM), and the human gastric simulator (HGS), have been developed to mimic the postprandial state of the stomach. While these models have assisted in expanding physiological relevance of in vitro dissolution tests, in general, these models lack the ability to fully replicate physiological conditions/processes. Furthermore, the translatability of in vitro data to an in vivo system remains challenging. Additionally, physiologically based pharmacokinetic (PBPK) modeling has been employed to evaluate the effect of food on drug bioavailability and bioequivalence. Here, we assess the current status of in vitro dissolution methodologies and absorption PBPK modeling approaches to identify knowledge gaps and facilitate further development of in vitro dissolution methods that factor in fasted and fed states. Prediction of in vivo drug performance under fasted and fed conditions via in vitro dissolution testing and modeling may potentially help efforts in harmonizing global regulatory recommendations regarding in vivo fasted and fed bioequivalence studies for solid oral IR products.
Development, structural characterization, in vitro and bioavailability studies of novel surface modified natural Fiber Interlaced Liposomal Vitamin C

Joby Jacob,Vedashree M. Sharma,T.V. Valsaraj,Heggar Venkataramana Sudeep,Jestin Thomas,Shyamprasad Kodimule

DOI: https://doi.org/10.1039/d4nj03773a

IF: 3.3

2024-10-18

New Journal of Chemistry

Abstract:New design techniques are required to improve the stability of vitamin C (VC) which is essential for human health but sensitive to environmental factors, in stomach and release in the body. The purpose of this research is to develop and characterise a Fibre Interlaced Liposome (FIL) as a vehicle for a better delivery platform for VC, when fruit fibres provide surface protection against degradation which was confirmed by the various studies. The optimised formulation was evaluated for its structural and surface morphological properties by zeta potential, FTIR, XRD, SEM, TEM, and DSC analyses. In vitro release studies were also done and FIL-VC displayed a sustained release of VC (19.31%) as compared to the control (67.54%) after 8 h. The FIL-VC has better release in simulated intestinal fluids (95%) than gastric fluids (21%) indicate the better absorption in the gastro intestinal tract. In a randomized, double-blind, active-controlled, two-way crossover clinical study FIL-VC showed a 5.77-fold higher relative oral bioavailability in comparison with the unformulated VC. The AUC0-t for VC in FIL-VC (23.80 μg/mL) was found to be significantly higher compared to unformulated VC (4.13 μg/mL) after the oral administration of a single dose. These data show that FIL formulation resulted a sustained release of VC with increased bioavailability, which could be beneficial for extended-release applications.

chemistry, multidisciplinary
Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution

Alex Yu,Mark J. Koenigsknecht,Bart Hens,Jason R. Baker,Bo Wen,Trachette L. Jackson,Manjunath P. Pai,William Hasler,Gordon L. Amidon,Duxin Sun

DOI: https://doi.org/10.1208/s12248-019-0385-z

2019-01-01

The AAPS Journal

Abstract:Multiple approaches such as mathematical deconvolution and mechanistic oral absorption models have been used to predict in vivo drug dissolution in the gastrointestinal (GI) tract. However, these approaches are often validated by plasma pharmacokinetic profiles, but not by in vivo drug dissolution due to the limited data available regarding the local GI environment. It is also challenging to predict and validate in vivo dissolution in different regions of the GI tract (stomach, duodenum, jejunum, and ileum). In this study, the dynamic fluid compartment absorption and transport (DFCAT) model was used to predict the in vivo dissolution profiles of ibuprofen, which was administered as an 800-mg immediate-release tablet to healthy subjects, in different regions of the GI tract. The prediction was validated with concentration time-courses of ibuprofen (BCS class 2a) in different regions of the GI tract that we have obtained over the past few years. The computational model predicted that the dissolution of ibuprofen was minimal in the stomach (2%), slightly more in the duodenum (6.3%), and primarily dissolved in the jejunum (63%) and the ileum (25%). The detailed model prediction of drug dissolution in different regions of GI can provide a quantitative reference of in vivo dissolution that may provide valuable insight in developing in vitro tests for drug product optimization and quality.
Physiologically based Pharmacokinetic Models under the Prism of the Finite Absorption Time Concept

Di Wu,Athanasios A. Tsekouras,Panos Macheras,Filippos Kesisoglou

DOI: https://doi.org/10.1007/s11095-022-03357-0

IF: 4.58

2022-09-03

Pharmaceutical Research

Abstract:To date, mechanistic modeling of oral drug absorption has been achieved via the use of physiologically based pharmacokinetic (PBPK) modeling, and more specifically, physiologically based biopharmaceutics model (PBBM). The concept of finite absorption time (FAT) has been developed recently and the application of the relevant physiologically based finite time pharmacokinetic (PBFTPK) models to experimental data provides explicit evidence that drug absorption terminates at a specific time point. In this manuscript, we explored how PBBM and PBFTPK models compare when applied to the same dataset. A set of six compounds with clinical data from immediate-release formulation were selected. Both models resulted in absorption time estimates within the small intestinal transit time, with PBFTPK models generally providing shorter time estimates. A clear relationship between the absorption rate and the product of permeability and luminal concentration was observed, in concurrence with the fundamental assumptions of PBFTPK models. We propose that future research on the synergy between the two modeling approaches can lead to both improvements in the initial parameterization of PBPK/PBBM models but to also expand mechanistic oral absorption concepts to more traditional pharmacometrics applications.

pharmacology & pharmacy,chemistry, multidisciplinary
The tangential flow absorption model (TFAM) - A novel dissolution method for evaluating the performance of amorphous solid dispersions of poorly water-soluble actives

Bastian Haering,Stefan Seyferth,Heiko A Schiffter

DOI: https://doi.org/10.1016/j.ejpb.2020.06.013

Abstract:There is a substantial demand for absorptive dissolution tests, as single vessel dissolution experiments were originally not designed for testing supersaturating systems. Current approaches suffer from inadequate mass transfer of the dissolved active from the dissolution site, discrepancies in the fluid volume compared to in vivo intestinal fluid volumes or the dilution of functional excipients. In this work a novel dissolution apparatus was developed that enables adjustable mass transfer of the active through a membrane, while retaining the functional polymeric excipients at the dissolution site. Using this setup the dissolution behavior of various spray dried amorphous solid dispersions containing carbamazepine, hydrochlorothiazide and ketoconazole as model actives at intermediate and high supersaturation levels was evaluated. Compared to non-absorptive dissolution experiments, differences in the concentration-time profiles were noted. The experiments with a high supersaturation of ketoconazole revealed a concentration decrease over time under absorptive conditions. Additionally, it was observed that the difference between "spring" as well as "spring and parachute" formulations was less pronounced with increasing drug efflux. Further, the apparatus was also tested with Fasted State Simulated Intestinal Fluid as dissolution medium and results were compared to phosphate buffer pH6.8. As major benefits of the new TFAM apparatus the easy experimental procedure and sample preparation for drug concentration measurements using spectroscopy in the permeate, without the necessity for additional filtration and/or centrifugation to remove precipitated drug molecules, could be highlighted. This TFAM approach seems to be a promising tool for identifying formulations for amorphous solid dispersions with optimal in vitro performance.
SpinDoctor-IVIM: A virtual imaging framework for intravoxel incoherent motion MRI

Mojtaba Lashgari,Zheyi Yang,Miguel O Bernabeu,Jing-Rebecca Li,Alejandro F Frangi

DOI: https://doi.org/10.1016/j.media.2024.103369

Abstract:Intravoxel incoherent motion (IVIM) imaging is increasingly recognised as an important tool in clinical MRI, where tissue perfusion and diffusion information can aid disease diagnosis, monitoring of patient recovery, and treatment outcome assessment. Currently, the discovery of biomarkers based on IVIM imaging, similar to other medical imaging modalities, is dependent on long preclinical and clinical validation pathways to link observable markers derived from images with the underlying pathophysiological mechanisms. To speed up this process, virtual IVIM imaging is proposed. This approach provides an efficient virtual imaging tool to design, evaluate, and optimise novel approaches for IVIM imaging. In this work, virtual IVIM imaging is developed through a new finite element solver, SpinDoctor-IVIM, which extends SpinDoctor, a diffusion MRI simulation toolbox. SpinDoctor-IVIM simulates IVIM imaging signals by solving the generalised Bloch-Torrey partial differential equation. The input velocity to SpinDoctor-IVIM is computed using HemeLB, an established Lattice Boltzmann blood flow simulator. Contrary to previous approaches, SpinDoctor-IVIM accounts for volumetric microvasculature during blood flow simulations, incorporates diffusion phenomena in the intravascular space, and accounts for the permeability between the intravascular and extravascular spaces. The above-mentioned features of the proposed framework are illustrated with simulations on a realistic microvasculature model.
In vitro and in vivo correlation for lipid-based formulations: Current status and future perspectives

Yanping Huang,Qin Yu,Zhongjian Chen,Wei Wu,Quangang Zhu,Yi Lu

DOI: https://doi.org/10.1016/j.apsb.2021.03.025

IF: 14.903

2021-08-01

Acta Pharmaceutica Sinica B

Abstract:Lipid-based formulations (LBFs) have demonstrated a great potential in enhancing the oral absorption of poorly water-soluble drugs. However, construction of in vitro and in vivo correlations (IVIVCs) for LBFs is quite challenging, owing to a complex in vivo processing of these formulations. In this paper, we start with a brief introduction on the gastrointestinal digestion of lipid/LBFs and its relation to enhanced oral drug absorption; based on the concept of IVIVCs, the current status of in vitro models to establish IVIVCs for LBFs is reviewed, while future perspectives in this field are discussed. In vitro tests, which facilitate the understanding and prediction of the in vivo performance of solid dosage forms, frequently fail to mimic the in vivo processing of LBFs, leading to inconsistent results. In vitro digestion models, which more closely simulate gastrointestinal physiology, are a more promising option. Despite some successes in IVIVC modeling, the accuracy and consistency of these models are yet to be validated, particularly for human data. A reliable IVIVC model can not only reduce the risk, time, and cost of formulation development but can also contribute to the formulation design and optimization, thus promoting the clinical translation of LBFs.

pharmacology & pharmacy
[The dissolution test in biorelevant media as a prognostic tool for modeling of drug behavior in vivo]

G V Ramenskaia,I E Shokhin,A Iu Savchenko,E A Volkova

DOI: https://doi.org/10.18097/pbmc20115705482

Abstract:The review deals with the modern tool for modeling of drug behavior in vivo, - the dissolution test in biorelevant media, imitating gastrointestinal fluids. The formulations and preparation methods of fasted state simulation intestinal fluid, FaSSIF and fed state simulation intestinal fluid, FeSSIF, are defined. In addition, the dissolution characteristics of APIs from different BCS classes in biorelevant media are described. Possible applications of biorelevant media in regulatory practice and science are also shown.
Mechanistic Fluid Transport Model to Estimate Gastrointestinal Fluid Volume and Its Dynamic Change over Time

Alex Yu,Trachette Jackson,Yasuhiro Tsume,Mark Koenigsknecht,Jeffrey Wysocki,Luca Marciani,Gordon L. Amidon,Ann Frances,Jason R. Baker,William Hasler,Bo Wen,Amit Pai,Duxin Sun

DOI: https://doi.org/10.1208/s12248-017-0145-x

2017-01-01

The AAPS Journal

Abstract:Gastrointestinal (GI) fluid volume and its dynamic change are integral to study drug disintegration, dissolution, transit, and absorption. However, key questions regarding the local volume and its absorption, secretion, and transit remain unanswered. The dynamic fluid compartment absorption and transit (DFCAT) model is proposed to estimate in vivo GI volume and GI fluid transport based on magnetic resonance imaging (MRI) quantified fluid volume. The model was validated using GI local concentration of phenol red in human GI tract, which was directly measured by human GI intubation study after oral dosing of non-absorbable phenol red. The measured local GI concentration of phenol red ranged from 0.05 to 168 μg/mL (stomach), to 563 μg/mL (duodenum), to 202 μg/mL (proximal jejunum), and to 478 μg/mL (distal jejunum). The DFCAT model characterized observed MRI fluid volume and its dynamic changes from 275 to 46.5 mL in stomach (from 0 to 30 min) with mucus layer volume of 40 mL. The volumes of the 30 small intestine compartments were characterized by a max of 14.98 mL to a min of 0.26 mL (0–120 min) and a mucus layer volume of 5 mL per compartment. Regional fluid volumes over 0 to 120 min ranged from 5.6 to 20.38 mL in the proximal small intestine, 36.4 to 44.08 mL in distal small intestine, and from 42 to 64.46 mL in total small intestine. The DFCAT model can be applied to predict drug dissolution and absorption in the human GI tract with future improvements.
Progressive tools and critical strategies for development of best fit PBPK model aiming better in vitro-in vivo correlation

Arnav Golhar,Megha Pillai,Pooja Dhakne,Niraj Rajput,Tarang Jadav,Pinaki Sengupta

DOI: https://doi.org/10.1016/j.ijpharm.2023.123267

2023-08-25

Abstract:Nowadays, conducting discriminative dissolution experiments employing physiologically based pharmacokinetic modeling (PBPK) or physiologically based biopharmaceutical modeling (PBBM) is gaining significant importance in quantitatively predicting oral absorption of drugs. Mechanistic understanding of each process involved in drug absorption and its impact on the performance greatly facilitates designing a formulation with high confidence. Unfortunately, the biggest challenge scientists are facing in current days is the lack of standardized protocol for integrating dissolution experiment data during PBPK modeling. However, in vitro-in vivo drug release interrelation can be improved with the consideration and development of appropriate biorelevant dissolution media that closely mimic physiological conditions. Multiple reported dissolution models have described nature and functionality of different regions of the gastrointestinal tract (GI) to more accurately design discriminative dissolution media. Dissolution experiment data can be integrated either mechanistically or without a mechanism depending primarily on the formulation type, biopharmaceutics classification system (BCS) class and particle size of the drug substance. All such parameters are required to be considered for selecting the appropriate functions during PBPK modeling to produce a best fit model. The primary focus of this review is to critically discuss various progressive dissolution models and tools, existing challenges and approaches for establishing best fit PBPK model aiming better in vitro-in vivo correlation (IVIVC). Strategies for proper selection of dissolution models as an input function in PBPK/PBBM modeling have also been critically discussed. Logical and scientific pathway for selection of different type of functions and integration events in the commercially available in silico software has been described through case studies.

IVIVC Revised

Application of the Finite Absorption Time (F.A.T.) Concept in the Assessment of Bioequivalence

IV-IVC considerations in the development of immediate-release oral dosage form

Conventional vs Mechanistic IVIVC: A Comparative Study in Establishing Dissolution Safe Space for Extended Release Formulations

FDA and EMA Oversight of Disruptive Science on Application of Finite Absorption Time (F.A.T.) Concept in Oral Drug Absorption: Time for Scientific and Regulatory Changes

Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts

A time-scaled convolution approach to construct IVIVC for enteric-coated acetylsalicylic acid tablets

FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms

Direct, differential-equation-based in-vitro-in-vivo correlation (IVIVC) method

In vivo dissolution of poorly water-soluble drugs: Proof of concept based on fluorescence bioimaging

Assessment of fitting methods and variability of IVIM parameters in muscles of the lumbar spine at rest

Development of in Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms

Development, structural characterization, in vitro and bioavailability studies of novel surface modified natural Fiber Interlaced Liposomal Vitamin C

Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug Dissolution

Physiologically based Pharmacokinetic Models under the Prism of the Finite Absorption Time Concept

The tangential flow absorption model (TFAM) - A novel dissolution method for evaluating the performance of amorphous solid dispersions of poorly water-soluble actives

SpinDoctor-IVIM: A virtual imaging framework for intravoxel incoherent motion MRI

In vitro and in vivo correlation for lipid-based formulations: Current status and future perspectives

[The dissolution test in biorelevant media as a prognostic tool for modeling of drug behavior in vivo]

Mechanistic Fluid Transport Model to Estimate Gastrointestinal Fluid Volume and Its Dynamic Change over Time

Progressive tools and critical strategies for development of best fit PBPK model aiming better in vitro-in vivo correlation